Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1963 2
1964 3
1967 3
1968 2
1969 3
1970 3
1971 5
1973 3
1974 1
1975 3
1976 5
1977 2
1978 3
1979 3
1980 6
1981 10
1982 13
1983 8
1984 5
1985 7
1986 1
1987 3
1988 10
1989 10
1990 9
1991 10
1992 11
1993 8
1994 15
1995 24
1996 31
1997 24
1998 27
1999 31
2000 34
2001 30
2002 27
2003 38
2004 57
2005 57
2006 54
2007 60
2008 85
2009 89
2010 110
2011 108
2012 112
2013 108
2014 113
2015 130
2016 129
2017 104
2018 97
2019 132
2020 177
2021 181
2022 179
2023 188
2024 90

Text availability

Article attribute

Article type

Publication date

Search Results

2,442 results

Results by year

Filters applied: . Clear all
The following term was not found in PubMed: Ying-Tzy
Page 1
ILC2s-Bipartisan politicians in cancer.
Zebboudj A, Amisaki M, Balachandran VP. Zebboudj A, et al. Sci Immunol. 2022 Jun 3;7(72):eabq2791. doi: 10.1126/sciimmunol.abq2791. Epub 2022 Jun 3. Sci Immunol. 2022. PMID: 35658014 Free PMC article. Review.
Group 2 innate lymphoid cells (ILC2s) are lymphocytes that both promote and suppress antitumor immunity. Jou and colleagues now report in colorectal tumorigenesis that the cytokine interleukin-25 activates ILC2s to induce myeloid cells that suppress antitumor immunity....
Group 2 innate lymphoid cells (ILC2s) are lymphocytes that both promote and suppress antitumor immunity. Jou and colleagues now repor …
Histopathology in HCM.
Tejado BSM, Jou C. Tejado BSM, et al. Glob Cardiol Sci Pract. 2018 Aug 12;2018(3):20. doi: 10.21542/gcsp.2018.20. Glob Cardiol Sci Pract. 2018. PMID: 30393632 Free PMC article. Review. No abstract available.
Hepatocellular Carcinoma Surveillance.
Jou JH, Muir AJ. Jou JH, et al. Clin Gastroenterol Hepatol. 2018 Jan;16(1):19-20. doi: 10.1016/j.cgh.2017.06.049. Epub 2017 Jul 8. Clin Gastroenterol Hepatol. 2018. PMID: 28694129 No abstract available.
Systemic Sclerosis and the Liver.
Green EW, Kahl L, Jou JH. Green EW, et al. Clin Liver Dis (Hoboken). 2021 Sep 6;18(2):76-80. doi: 10.1002/cld.1074. eCollection 2021 Aug. Clin Liver Dis (Hoboken). 2021. PMID: 34584672 Free PMC article. Review. No abstract available.
A New Switch for TGFβ in Cancer.
Yeh HW, Lee SS, Chang CY, Lang YD, Jou YS. Yeh HW, et al. Cancer Res. 2019 Aug 1;79(15):3797-3805. doi: 10.1158/0008-5472.CAN-18-2019. Epub 2019 Jul 12. Cancer Res. 2019. PMID: 31300476 Review.
Safe Zones for Percutaneous Carpal Tunnel Release.
Wu PT, Chern TC, Wu TT, Shao CJ, Wu KC, Kuo LC, Jou IM. Wu PT, et al. Hand Clin. 2022 Feb;38(1):83-90. doi: 10.1016/j.hcl.2021.08.008. Hand Clin. 2022. PMID: 34802612 Review.
Toeing the line between regeneration and fibrosis.
Jou V, Lehoczky JA. Jou V, et al. Front Cell Dev Biol. 2023 Jun 1;11:1217185. doi: 10.3389/fcell.2023.1217185. eCollection 2023. Front Cell Dev Biol. 2023. PMID: 37325560 Free PMC article. Review.
Macrophage-mediated inflammatory disorders.
Jou IM, Lin CF, Tsai KJ, Wei SJ. Jou IM, et al. Mediators Inflamm. 2013;2013:316482. doi: 10.1155/2013/316482. Epub 2013 Jun 13. Mediators Inflamm. 2013. PMID: 23843681 Free PMC article. No abstract available.
2,442 results